Global Ganja Report

Compassionate care—providing medical marijuana to the ill—was what first opened legal space for cannabis in California a generation ago. But the state's Adult Use of Marijuana Act only regulates commercial businesses—leaving caregivers in legal limbo.

The election of Andres Manuel Lopez Obrador—known by his initials AMLO—as Mexico's next president is being hailed as historic, marking the first time a candidate of the left has had his victory honored. He is pledging a new, demilitarized approach to ending the endemic narco-violence. And his newly named interior minister is a vocal supporter of cannabis legalization. Will a day-lightened cannabis sector provide a way out of Mexico's long crisis?

In another sign of turning tides, a prestigious British think-tank once beloved of Margaret Thatcher has called on the government to legalize cannabis. The breakthrough report finds that a legal cannabis industry could raise £1 billion per year in tax revenues for the United Kingdom, while undercutting the black market.

With Canada now joining Uruguay as the second country to legalize cannabis at the national level, industry eyes are scanning the world map for which could be the likely third. Latin America may provide the candidate, as even UN experts now urge the region's governments to consider legalization as a way out of the endemic narco-violence. But pressure for legal cannabis is fast mounting in several European countries as well. Legalization may soon be on the legislative agenda in Australia, while New Zealand has promised to put the questions before the voters. 

The doctrine of nullification has a long and harshly contested legacy in the history of the United States—it has been invoked in defense of both just causes and frankly evil ones. But some argue that it is time to revisit the idea—to put an end to federal cannabis prohibition.

For a generation now, science has known of two cannabinoid receptors—specialized protein molecules that interact with the active compounds in the cannabis plant for the human body. These are CB1 and CB2, both discovered in the early '90s. Now there is growing awareness of a third such receptor that was identified in 2007. This receptor, GPR55, may be key to understanding a wide spectrum of therapeutic applications for cannabinoids—and especially the non-psychoactive cannabidiol, or CBD.

Canada is about to make history, with passage of its cannabis legalization bill imminent. Prime Minister Justin Trudeau  is the man of the hour, shepherding the first Western industrialized country along a course that was nearly unthinkable a generation ago. But it was activist efforts that really brought Canada to this point—and advocates are still fighting to keep a place for small growers and vendors in the new system.

The government of New Zealand has announced that it plans to hold a referendum on cannabis legalization, possibly as early as next year. A medical marijuana bill is already pending in the country's parliament. But it has taken generations of activist effort by Kiwis to bring Aotearoa (by the country's indigenous Maori name) to this point. Cannabis Now speaks with some of the leaders who made it happen.